Systems Biology Approach to the Mechanisms of TB Latency and Reactivation (R01)
The summary for the Systems Biology Approach to the Mechanisms of TB Latency and Reactivation (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Systems Biology Approach to the Mechanisms of TB Latency and Reactivation (R01): Purpose. The National Heart, Lung, and Blood Institute solicits Research Project Grant (R01) applications under this funding opportunity announcement (FOA) to investigate the mechanisms of latency and the reactivation of tuberculosis in the host using integrated systems biology approaches. Systems biology is defined in many ways. For the purposes of this FOA we are using a definition found on the MIT CSBi website: research program that links biologists, computer scientists, and engineers in a multi disciplinary approach to the systematic analysis of complex biological phenomena. The studies should include multiscale computational modeling and focus on host lung responses to Mycobacterium tuberculosis (Mtb) and host-microbial interactions that drive latency and reactivation in humans. To build the theoretical models, human and animal data should be utilized. The studies should integrate the data obtained from omic approaches with biological/immunological data. The models should be such that they can be tested in humans or non-human primates. The use of human samples and or data is required. Applicants are strongly encouraged to use the multiple principal investigator mechanism to facilitate collaborations among investigators with expertise in mathematics and computational multiscale modeling and clinical investigators and experimental biologists who have expertise in tuberculosis, pulmonology, lung biology, immunology, microbiology, genomics, genetics, other omics, and infectious diseases. Applicants are also strongly urged to include bioengineers and physicists in the research groups to enable teams of investigators to take advantage of new and developing technologies likely to be needed both to obtain biological data for building the computational models and for testing hypotheses generated by them. This FOA solicits applications for the TB Systems Biology Centers and runs in parallel with a separate FOA that solicits applications for a Data Coordinating Center (see RFA-HL-10-022).
|Federal Grant Title:||Systems Biology Approach to the Mechanisms of TB Latency and Reactivation (R01)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-HL-10-015|
|Type of Funding:||Grant|
|CFDA Descriptions:||Lung Diseases Research|
|Current Application Deadline:||Mar 24, 2010|
|Original Application Deadline:||Mar 24, 2010|
|Posted Date:||Dec 09, 2009|
|Creation Date:||Dec 09, 2009|
|Archive Date:||Apr 24, 2010|
|Total Program Funding:||$3,450,000|
|Maximum Federal Grant Award:||$250,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
- Similar Government Grants
- • Advancing Novel Research Models to Study Idiopathic Pulmonary Fibrosis (U01 Clinical Trial...
- • Management of Asthma in Primary Care - Bioinformatics Center (U24 - Clinical Trial Require...
- • Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required)
- • Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Data Coordinating Center (...
- • Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Human Tissue Core (U01- Cl...
- • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
- • Lung Response to Inhaled Highly Toxic Chemicals
- • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...